Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging-Reference-Cited by-同舟云学术

Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging

Published:2024-07-22 Issue:9 Volume:29 Page:1347-1353
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yamaguchi Kohei,Tsuruga Tetsushi,Taguchi Ayumi,Tanikawa Michihiro,Sone Kenbun,Mori-Uchino Mayuyo,Iriyama Takayuki,Matsumoto Yoko,Hiraike Osamu,Hirota Yasushi,Fujii Tomoyuki,Osuga Yutaka

Funder

the Japanese Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10147-024-02561-9.pdf

Reference17 articles.

1. Varki A (2007) Trousseau’s syndrome: Multiple definitions and multiple mechanisms. Blood 110(6):1723–1729. https://doi.org/10.1182/blood-2006-10-053736

2. Timp JF, Braekkan SK, Versteeg HH et al (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122(10):1712–1723. https://doi.org/10.1182/blood-2013-04-460121

3. Sorensen HT, Mellemkjar L, Olsen JH et al (2000) (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846–1850. https://doi.org/10.1056/NEJM200012213432504

4. Levitan N, Dowlati A, Remick SC et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy Risk analysis using Medicare claims data. Medicine (Baltimore) 78(5):285–291. https://doi.org/10.1097/00005792-199909000-00001

5. Blom JW, Vanderschoot JPM, Oostindier MJ et al (2006) Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: Results of a record linkage study. J Thromb Haemost 4(3):529–535